City

Rotterdam (2)

Amsterdam (1)

Ancona (1)

Antwerp (1)

Berlin (1)

Leicester (1)

Lille (1)

Toronto (1)

Youngstown (1)

Overall Status

Completed (3)

Recruiting (2)

Phase

n/a (1)

phase 1 (1)

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Amphera BV (1)

Charite University, Berlin, Germany (1)

Joachim Aerts, MD PhD (1)

Marcus Migura (1)

University Health Network, Toronto (1)

Collaborator

Amgen (1)

Mercy Health (1)

National Multiple Sclerosis Society (1)

NeuroCure Clinical Research Center, Charite, Berlin (1)

TMC Pharma (1)

Universitatsklinikum Hamburg-Eppendorf (1)

Study Documents

Individual Participant Data Set (1)

Informed Consent Form (1)

Primary Outcome Ultrasound Images (1)

Intervention Type

drug (2)

other (2)

biological (1)

device (1)

dietary supplement (1)

Funder Type

Other (4)

Industry (1)

Study Type

Interventional (4)

Observational (1)

DENIM

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Depression and Immune Function in Multiple Sclerosis (MS)

Completed

Multiple Sclerosis
Depressive Disorder, Major

No intervention

Berlin, Germany

Charité - Universitätsmedizin Berlin

Jul 28, 2021

Metastatic Pancreatic Cancer Trial in Rotterdam (MesoPher, Mitazalimab)

Recruiting

Metastatic Pancreatic Cancer

MesoPher
Mitazalimab

Rotterdam, Zuid-Holland, Netherlands

Erasmus MC

Dec 6, 2022

Mesothelioma Trial in Worldwide (MesoPher)

Recruiting

Mesothelioma

MesoPher

Antwerp, Belgium
+5 more

Jan 26, 2021

Urothelial Carcinoma, Kidney Cancer, Ureter Cancer Trial in Toronto (drug, other, dietary supplement)

Completed

Urothelial Carcinoma
+3 more

Denosumab
+6 more

Toronto, Ontario, Canada

Princess Margaret Cancer Centre

Nov 22, 2021

Hemorrhage, Vascular Injury Trial in Youngstown (Pneumatic Tourniquet, One Windlass Tourniquet, Two Windlass Tourniquets)

Completed

Has Results

Hemorrhage
Vascular Injury

Pneumatic Tourniquet
+4 more

Youngstown, Ohio

Vascular Medicine & Surgical Associates

Aug 22, 2017